Gritsina, Galina

Publications

Sort by

Co-Author Network

Chemokine receptor CXCR7 activates Aurora Kinase A and promotes neuroendocrine prostate cancer growth. The Journal of clinical investigation. 2023 Academic Article GET IT
CXCR7 as a novel therapeutic target for advanced prostate cancer. Oncogene. 2023 Review GET IT
Times cited: 5
FOXA1 inhibits hypoxia programs through transcriptional repression of HIF1A. Oncogene. 2022 Academic Article GET IT
Times cited: 6
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer. Nature genetics. 2022 Academic Article GET IT
Times cited: 29
Correction: Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. 2020 GET IT
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer. Cancer research. 2019 Academic Article GET IT
Times cited: 78
Transcriptional repression by androgen receptor: roles in castration-resistant prostate cancer. Asian journal of andrology. 2019 Review GET IT
Times cited: 20